Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research on Efficacy of Teriparatide use in the Return of recruits to Normal duty

X
Trial Profile

Research on Efficacy of Teriparatide use in the Return of recruits to Normal duty

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Fracture; Osteoporosis
  • Focus Therapeutic Use
  • Acronyms RETURN
  • Most Recent Events

    • 21 Sep 2021 protocol of study is amended for calcium and vitD supplement if serum calcium is less than 2mmo/l ;requirement for participants to be prescribed vitamin D as part of standard care(if vitamin D deficient); MRI scans at weeks 20 and 24, if a fracture remains unhealed at week 16; a subgroup of participants to wear accelerometers to assess physical activity levels; clarification regarding randomisation where allocation will stratified by vit D status and single or multiple lower body stress fracture
    • 30 Aug 2021 Trial design, published in the Trials
    • 03 Nov 2020 Planned End Date changed from 2 Apr 2021 to 1 Oct 2022.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top